Skip to main content
OpenTrials
Completed

NCT Number: NCT03037957

A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

A multi-center evaluation to assess the diagnostic sensitivity and specificity of the ARIES Group A Strep Assay will be established through a method comparison using prospectively collected, de-identified, clinical samples collected during the enrollment period.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Children's Hospital Los Angeles, Los Angeles, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient and/or patient's legal guardian is willing and able to give informed consent and/or assent for extra research sample.
  • The subject's specimen is a throat swab in Liquid Amies based transport medium.
  • The specimen is from an adult or pediatric, male or female subject who is either hospitalized, admitted to a hospital emergency department, visiting an outpatient clinical or resident of a long term care facility.
  • The specimen is from a patient for whom a requisition has been made for Group A Strep testing
  • The specimen is from a patient exhibiting clinical signs and symptoms of pharyngitis consistent with Group A Strep infection.
  • The specimen was received in good condition (no leakage or drying of the specimen).
  • The specimen volume is ≥ 850 µL.

Exclusion criteria

  • The specimen is from a patient who did not provide informed consent/assent.
  • The specimen is not a throat swab collected in Liquid Amies based transport medium.
  • The specimen is from a patient who is undergoing antibiotic treatment.
  • The specimen was not properly collected, transported, processed or stored according to the instructions provided by the Sponsor in Section 9 below.
  • The specimen volume is < 850 µL.

Treatment and study plan

ARIES Group A Strep Assay

Device

Primary outcomes

  1. Clinical performance (sensitivity/specificity) for Group A Strep Assay

    Time frame: Day 1

Sponsors and collaborators

Lead sponsor

Luminex Corporation

Industry

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jan 31, 2017
Registry last updated
Jul 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.